Arab, H.H.; Eid, A.H.; Alsufyani, S.E.; Ashour, A.M.; Alnefaie, A.M.; Alsharif, N.M.; Alshehri, A.M.; Almalawi, A.A.; Alsowat, A.A.; Abd El Aal, H.A.;
et al. Activation of AMPK/mTOR-Driven Autophagy and Suppression of the HMGB1/TLR4 Pathway with Pentoxifylline Attenuates Doxorubicin-Induced Hepatic Injury in Rats. Pharmaceuticals 2024, 17, 681.
https://doi.org/10.3390/ph17060681
AMA Style
Arab HH, Eid AH, Alsufyani SE, Ashour AM, Alnefaie AM, Alsharif NM, Alshehri AM, Almalawi AA, Alsowat AA, Abd El Aal HA,
et al. Activation of AMPK/mTOR-Driven Autophagy and Suppression of the HMGB1/TLR4 Pathway with Pentoxifylline Attenuates Doxorubicin-Induced Hepatic Injury in Rats. Pharmaceuticals. 2024; 17(6):681.
https://doi.org/10.3390/ph17060681
Chicago/Turabian Style
Arab, Hany H., Ahmed H. Eid, Shuruq E. Alsufyani, Ahmed M. Ashour, Alwaleed M. Alnefaie, Nasser M. Alsharif, Abdullah M. Alshehri, Abdulmajeed A. Almalawi, Abdulmajeed A. Alsowat, Hayat A. Abd El Aal,
and et al. 2024. "Activation of AMPK/mTOR-Driven Autophagy and Suppression of the HMGB1/TLR4 Pathway with Pentoxifylline Attenuates Doxorubicin-Induced Hepatic Injury in Rats" Pharmaceuticals 17, no. 6: 681.
https://doi.org/10.3390/ph17060681
APA Style
Arab, H. H., Eid, A. H., Alsufyani, S. E., Ashour, A. M., Alnefaie, A. M., Alsharif, N. M., Alshehri, A. M., Almalawi, A. A., Alsowat, A. A., Abd El Aal, H. A., Hassan, E. S. G., Elesawy, W. H., & Elhemiely, A. A.
(2024). Activation of AMPK/mTOR-Driven Autophagy and Suppression of the HMGB1/TLR4 Pathway with Pentoxifylline Attenuates Doxorubicin-Induced Hepatic Injury in Rats. Pharmaceuticals, 17(6), 681.
https://doi.org/10.3390/ph17060681
